BN Business News
Add your company to Business Communicator →

Business · 24/08/2018

FDA Releases Draft Guidance on Placebos and Blinding in Cancer Clinical Trials

The FDA has released a draft guidance for industry on the use of placebos and blinding in clinical trials for cancer treatments, focusing on hematologic malignancies and oncologic diseases.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights